COVX-HT
Vivera Pharmaceuticals Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90356479 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Bruce Hare |
| Attorney Docket Number | VIV-T016K-N1 |
Timeline
| 2020-12-03 | Application Filed |
| 2020-12-07 | Location: NEW APPLICATION PROCESSING |
| 2020-12-07 | Status: Live/Pending |
| 2020-12-07 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Vivera Pharmaceuticals Inc. |
| Address | 4533 Macarthur Blvd, #5049 Newport Beach NV 92660 |
| Legal Entity Type | Corporation |
| Legal Entity State | NV |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Medical specimen bags for holding body tissue samples for testing purposes; Medical specimen collection devices in the nature of home collection kits for the collection of medical specimens; Medical specimen cups |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-12-07 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-02-08 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-04-23 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-04-27 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-04-27 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-04-27 | 6 GNRN O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2021-04-27 | 7 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-04-27 | 8 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-04-27 | 9 GNRN O:Outgoing Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2021-09-09 | 10 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-09-16 | 11 ALIE A:Allowance for Publication |
| PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2021-09-17 | 12 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2021-09-23 | 13 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-09-30 | 14 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-09-30 | 15 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-09-30 | 16 GNRN O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2022-04-15 | 17 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2022-04-15 | 18 MAB2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2022-04-15 | 19 MAB2 E:E-Mail |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED | 2024-03-07 | 20 WOAR I:Incoming Correspondence |
| WITHDRAWAL OF ATTORNEY GRANTED | 2024-03-07 | 21 WOAG I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2024-03-07 | 22 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2024-03-07 | 23 CHAN I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-03-07 | 24 TCCA I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 